These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 10392670)
41. Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation. Cinciripini PM; Tsoh JY; Wetter DW; Lam C; de Moor C; Cinciripini L; Baile W; Anderson C; Minna JD Exp Clin Psychopharmacol; 2005 Nov; 13(4):282-92. PubMed ID: 16366758 [TBL] [Abstract][Full Text] [Related]
42. Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia. Tidey JW; O'Neill SC; Higgins ST Exp Clin Psychopharmacol; 2002 Aug; 10(3):241-7. PubMed ID: 12233984 [TBL] [Abstract][Full Text] [Related]
43. Application of urine nicotine and cotinine excretion rates to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy. Lawson GM; Hurt RD; Dale LC; Offord KP; Croghan IT; Schroeder DR; Jiang NS J Clin Pharmacol; 1998 Jun; 38(6):510-6. PubMed ID: 9650540 [TBL] [Abstract][Full Text] [Related]
44. The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day. Daughton DM; Fortmann SP; Glover ED; Hatsukami DK; Heatley SA; Lichtenstein E; Repsher L; Millatmal T; Killen JD; Nowak RT; Ullrich F; Patil KD; Rennard SI Prev Med; 1999 Feb; 28(2):113-8. PubMed ID: 10048102 [TBL] [Abstract][Full Text] [Related]
45. Pre-cessation nicotine replacement therapy: pragmatic randomized trial. Bullen C; Howe C; Lin RB; Grigg M; Laugesen M; McRobbie H; Glover M; Walker N; Wallace-Bell M; Whittaker R; Rodgers A Addiction; 2010 Aug; 105(8):1474-83. PubMed ID: 20528810 [TBL] [Abstract][Full Text] [Related]
49. The pros and cons of transdermal nicotine therapy. Gourlay S Med J Aust; 1994 Feb; 160(3):152-9. PubMed ID: 8295585 [TBL] [Abstract][Full Text] [Related]
50. Response to nicotine dependence treatment in smokers with current and past alcohol problems. Hays JT; Schroeder DR; Offord KP; Croghan IT; Patten CA; Hurt RD; Jorenby DE; Fiore MC Ann Behav Med; 1999; 21(3):244-50. PubMed ID: 10626032 [TBL] [Abstract][Full Text] [Related]
51. A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part B: Safety and subjective effects. Walele T; Sharma G; Savioz R; Martin C; Williams J Regul Toxicol Pharmacol; 2016 Feb; 74():193-9. PubMed ID: 26702788 [TBL] [Abstract][Full Text] [Related]
52. Comparison of the effects of a 24-hour nicotine patch and a 16-hour nicotine patch on smoking urges and sleep. Aubin HJ; Luthringer R; Demazières A; Dupont C; Lagrue G Nicotine Tob Res; 2006 Apr; 8(2):193-201. PubMed ID: 16766412 [TBL] [Abstract][Full Text] [Related]
53. Case studies of three pregnant smokers and their use of nicotine replacement therapy. Hotham ED; Gilbert AL; Atkinson ER Midwifery; 2005 Sep; 21(3):224-32. PubMed ID: 15967546 [TBL] [Abstract][Full Text] [Related]
55. Randomized, double-blind, placebo-controlled study of transdermal nicotine patch for smoking cessation. Perng RP; Hsieh WC; Chen YM; Lu CC; Chiang SJ J Formos Med Assoc; 1998 Aug; 97(8):547-51. PubMed ID: 9747065 [TBL] [Abstract][Full Text] [Related]
56. The safety, tolerability and efficacy of transdermal nicotine (Nicotinell TTS) in initially hospitalised patients. Martin PD; Robinson GM N Z Med J; 1995 Jan; 108(992):6-8. PubMed ID: 7862363 [TBL] [Abstract][Full Text] [Related]
58. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial. Yudkin PL; Jones L; Lancaster T; Fowler GH Br J Gen Pract; 1996 Mar; 46(404):145-8. PubMed ID: 8731618 [TBL] [Abstract][Full Text] [Related]
59. Cotinine replacement levels for a 21 mg/day transdermal nicotine patch in an outpatient treatment setting. Gariti P; Alterman AI; Barber W; Bedi N; Luck G; Cnaan A Drug Alcohol Depend; 1999 Apr; 54(2):111-6. PubMed ID: 10217550 [TBL] [Abstract][Full Text] [Related]
60. Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study. Daughton DM; Heatley SA; Prendergast JJ; Causey D; Knowles M; Rolf CN; Cheney RA; Hatlelid K; Thompson AB; Rennard SI Arch Intern Med; 1991 Apr; 151(4):749-52. PubMed ID: 2012458 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]